Neurotransmitter system gene variants as biomarkers for the therapeutic efficacy of rTMS and SSRIs in obsessive-compulsive disorder
PurposeThis study aims to examine the potential influence of RS4680 (COMT), RS16965628 (SLC6A4), and RS1019385 (GRIN2B) polymorphisms on the therapeutic response to repetitive transcranial magnetic stimulation (rTMS) and selective serotonin reuptake inhibitors (SSRIs) in individuals with obsessive-c...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-05-01
|
| Colección: | Frontiers in Psychiatry |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1350978/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|